Tag Archives: Trial

COVID-19 Vaccine Trial Paused Due to Adverse Event

UPDATE: The trial of the AZD1222 vaccine in the U.K. has already resumed after an independent investigation by the Medicines Health Regulatory Authority concluded it was safe to proceed. “AstraZeneca is committed to the safety of trial participants and the highest standards of conduct in clinical trials,” the company said in a September 12 press release.… Read More »

‘Gold Standard’ Clinical Trial Finds Hydroxychloroquine Won’t Prevent COVID-19

WEDNESDAY, June 3, 2020 — Hydroxychloroquine, the malaria drug touted and reportedly used by President Donald Trump as a preventative for COVID-19, appears not to have lived up to its hype, a new study shows. Unlike some prior studies, this new trial was a “gold standard” prospective, randomized clinical trial. It found that hydroxychloroquine could… Read More »

SNBL CPC Completes Validation Trial of NeuroCart CNS Test Battery

Baltimore, MD (PRWEB) September 19, 2014 SNBL Clinical Pharmacology Center, Inc. (SNBL CPC), a 96-bed clinical pharmacology research unit specializing in complex early-phase trials, announced today the successful completion of a validation study of the NeuroCart. The study validated the NeuroCart as an effective tool for detection of benzodiazepine-evoked pharmacodynamic CNS effects.   The NeuroCart… Read More »